Medical Hypotheses
Volume 59, Issue 6 , Pages 615-621 , 12 November 2002

The porphyrin pathway: the final common pathway?

  • D.C. Downey

      Affiliations

    • Corresponding Author InformationCorrespondence to: D.C. Downey D.M.D., Oral Pathology Department, Gentle Dental, 16155 N.W. Cornell Road, Ste.450, Beaverton, Oregon, 97229 USA. Phone: +503-629-5300; fax: +503-690-9462

Received 2 July 2001 ,Accepted 1 November 2001.

References 

  1. Balch JF. The Super Anti-oxidants. New York: M. Evans and Company Inc; 1998;
  2. Sands L. Beat Arthritis Forever. Peterborough, Canada: Vectropy Publishing; 2000;
  3. Doss MO. Porphyrinurias and occupational disease. Ann. NY Acad. Sci. 1987;514:204–218
  4. Downey DC. Fatigue syndrome: new thoughts and reinterpretation of previous data. Med. Hypotheses. 1992;39:185–190
  5. Maines MD. New developments in the regulation of heme metabolism and their implications. CRC Crit. Rev. Toxicol. 1984;12:241–314
  6. Downey DC. Porphyrin enzyme analysis in an oral pathology practice: a look back over four years. Med. Hypotheses. 1996;46:563–568
  7. VA links Agent Orange and Type 11 Diabetes. Afterburner. January 2001:12
  8. Kang HK, Watanabe KK, Breen J, Remmers J, et al.  Dioxins and dibenxofurans in adipose tissue of US Vietnam veterans and controls. Am. J. Publ. Health. 1991;181:844–849
  9. Downey DC. Antioxidants: a theraphy for porphyria. Acta Haematol. 1997;98(suppl.1):446: 113
  10. Mauzerall DC. Evolution of porphyrins. Clin. Derm. 1998;16:195–201
  11. Duke SO, Rebeiz CA. Porphyric pesticides. ACS Symposium Series. vol. 559. American Chemical Society; 1994;
  12. Koeman JH, Debets FMH, Strik JJTWA. In:  Tordoir WF,  Heemstra-Lequin V editor. The Porphyrinogenic Potential of Pesticides with Special Emphasis on Organo-phosphorous Compounds. Field Worker Exposure During Pesticide Application, Studies in Environmental Science. vol. 7:New York: Elsevier; 1980;p. 157–162
  13. Krijt J, Stranska P, Maruna P, Vokurka M, Sanitrak J. Herbicide-induced experimental variegate porphyria in mice: tissue porphyrinogen accumulation and response to porphyrinogenic drugs. Can. J. Physiol. Pharmacol. 1997;75:1181–1187
  14. Koningsberger JC, Van Asbeck Bs, Van Hattum J, et al.  The effect of porphyrins on cellular redox systems a study of the dark effect of porphyrins on phagocytes. Euro. J. Clin. Invest. 1993;23:716–723
  15. Hermes-Lima M, Valle VGR, Vercesi AE, Bechara EJH. Damage to rat liver mitochondria promoted by delta aminolevulinic acid-generated reactive oxygen species connections with acute intermittent porphyria and lead poisoning. Biochem. Biophys. Acta. 1991;1056:57–63
  16. Demasi M, Penatti CAA, DeLucia R, Bechara EJH. The prooxidant effect of 5-aminolevulinic acid in the brain tissue of rats: implications in neuropsychiatric manifestations in porphyria. Free Radical Biol. Med. 1996;20:291–299
  17. Bannister JV, Bannister WH, Rotilio G. Aspects of the structure function and applications of superoxide dismutase. CRC Crit. Rev. Biochem. 1987;22:111–180
  18. Woods JS. Attenuation of porphyrinogen oxidation by glutathione in vitro and reversal by porphyrinogenic trace metals. Biochem. Biophys. Res. Commun. 1988;152:1428–1462
  19. Science News. Keeping antioxidants may spare gut. 2001;159: 248
  20. McCarty MF. Fish oil may be an antidote for the cardiovascular risk of smoking. Med. Hypotheses. 1996;46:337–347
  21. Doss MO, Sassa S. The porphyrias. In: Laboratory Medicine. USA: Williams and Wilkins; 1994;p. 535–553
  22. Downey DC. Porphyria: the road not traveled. Med. Hypotheses. 2001;56:73–76
  23. Lund-Olesen K. Etiology of multiple sclerosis: role of superoxide dismutase. Med. Hypotheses. 2000;54:321–322

PII: S0306-9877(02)00115-9

Medical Hypotheses
Volume 59, Issue 6 , Pages 615-621 , 12 November 2002

Article Tools

* Image Usage & Resolution